Affiliation:
1. Institute for Marine Sciences, Federal University of Ceara, Av da Abolicao 3207. Fortaleza/CE. 60165081, Brazil
Abstract
Since the beginning of written history, diverse texts have reported the use of enzymatic preparations in food processing and have described the medicinal properties of crude and fractionated venoms to treat various diseases and injuries. With the biochemical characterization of enzymes from distinct sources and bioactive polypeptides from animal venoms, the last sixty years have testified the advent of industrial enzymology and protein therapeutics, which are currently applicable in a wide variety of industrial processes, household products, and pharmaceuticals. Bioprospecting of novel biocatalysts and bioactive peptides is propelled by their unsurpassed properties that are applicable for current and future green industrial processes, biotechnology, and biomedicine. The demand for both novel enzymes with desired characteristics and novel peptides that lead to drug development, has experienced a steady increase in response to the expanding global market for industrial enzymes and peptidebased drugs. Moreover, although largely unexplored, oceans and marine realms, with their unique ecosystems inhabited by a large variety of species, including a considerable number of venomous animals, are recognized as untapped reservoirs of molecules and macromolecules (enzymes and bioactive venom-derived peptides) that can potentially be converted into highly valuable biopharmaceutical products. In this review, we have focused on enzymes and animal venom (poly)peptides that are presently in biotechnological use, and considering the state of prospection of marine resources, on the discovery of useful industrial biocatalysts and drug leads with novel structures exhibiting selectivity and improved performance.
Publisher
Bentham Science Publishers Ltd.
Subject
Cell Biology,Molecular Biology,Biochemistry,General Medicine
Reference158 articles.
1. Lewis CA, Wolfenden R. Proc Natl Acad Sci USA, Uroporphyrinogen decarboxylation as a benchmark for the catalytic proficiency of enzymes.,, 2008, 105,, 17328-17333,
2. Patel RN. Biomolecules, Biocatalytic synthesis of chiral alcohols and amino acids for development of pharmaceuticals.,, 2013, 3,, 741-777,
3. . , , FDA, Development of New Stereoisomeric Drugs, 1992
4. Zhang ZJ, Pan J, Ma BD, Xu JH. Adv Biochem Eng Biotechnol, Efficient biocatalytic synthesis of chiral chemicals.,, 2016, 155,, 55-106,
5. Rat’ko AA, Stefan-van Staden RI. Farmaco, Determination of baclofen enantiomers in pharmaceutical formulations using maltodextrin-based enantioselective, potentiometric membrane electrodes.,, 2004, 59,, 993-997,
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献